Skip to search formSkip to main contentSkip to account menu

0.6 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe [Lovenox]

Known as: 0.6 ML Lovenox 100 MG/ML Prefilled Syringe, 0.6 ML ENX sodium 100 MG/ML Prefilled Syringe [Lovenox], ENOXAPARIN SODIUM 60 mg in 0.6 mL SUBCUTANEOUS INJECTION [Lovenox] 
National Institutes of Health

Related topics

Related topics

6 relations
0.8 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe [Lovenox]EnoxaparinEnoxaparin sodiumLovenox

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Neue Aspekte zur Therapie der venösen Thromboembolie
New Therapy-Aspects of Venous Thromboembolism. Low-molecular-weight heparins given once or twice daily subcutaneously without… 
2016
2016
Comparability of âÂÂEnoxamedâ a Tunisian Generic Enoxaparin with theOriginator Product: Non-clinical and Clinical Studies
Enoxaparin is a complex, biologically derived low-molecular-weight heparin. The manufacturing process for biologics is complex… 
2015
2015
Generic and Branded Enoxaparin Bioequivalence: A Clinical andExperimental Study
Our aim is to compare a new generic version of enoxaparin (Enoxa®) with the parent brand (Lovenox®). We included patients with… 
2004
2004
Neue Aspekte zur Therapie der venösen Thromboembolie
New Therapy-Aspects of Venous Thromboembolism. Low-molecular-weight heparins given once or twice daily subcutaneously without… 
2000
2000
Increased dose requirements for Enoxiparin (Lovenox®) Low Molecular Weight Heparin (LMWH) in neonates, children, and adolescents
1995
1995
Histologische Veränderungen in den unterbundenen Stümpfen der Ovarialgefässe bei präoperativer niedermolekularer Heparinprophylaxe
Fragestellung: WAhrend einer Adnexektomie untersuchten wir thrombotische VerAnderungen sowie GefAsslAsionen und resezierten die…